Intellia Therapeutics Inc (NTLA)

Capital Expenditure

-$1.81M

Quarterly · Period ending: · USD

NTLA logo

NTLA Capital Expenditure

Latest reported-$1.81M
NTLA Quarterly CapEx ($0.00 → -$1.81M)
High-resolution chart · PNG

NTLA capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Intellia Therapeutics Inc Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-1,809,000
-79,000
-126,000
-29,000
-239,000
-735,000
-981,000
-1,279,000
-1,012,000
-2,506,000
-1,520,000
-4,332,000
-4,301,000
-3,832,000
-3,912,000
-4,237,000
-3,980,000
-46,261,000
-2,868,000
-4,538,000
-2,938,000
-2,412,000
-1,006,000
-698,000
-1,036,000
-845,000
-2,572,000
-1,748,000
-941,000
-1,533,000
-1,592,000
-2,016,000
-900,000
-1,850,000
-2,397,000
-2,260,000
-1,272,000
-4,162,000
-3,405,000
-605,000
-1,147,000
-1,008,000
-849,000
-602,000
-587,000
-516,000
-412,500
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.